Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The ...

Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...

In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International (WW – Research Report), with a ...